Central Drugs Standard Control Organisation

Drugs body CDSCO suspends import licences of 19 firms for non-USFDA COVID-19 testing kits

The decision was taken after the drug controller found the companies' response to a 17 July show-cause notice asking them to explain why their licences should not be suspended unsatisfactory

Gilead granted marketing authorisation for remdesivir for potential Covid-19 treatment in India

India has allowed adults and children who have been hospitalised with severe COVID-19 symptoms to be treated with Remdesivir

Remdesivir improved symptoms when administered to moderately ill COVID-19 patients: Gilead

The administration of this drug will be given to patients who show signs of a sever COVID-19 infection for a period of five days as well.

Alarming! Regulator approving drugs without scrutiny?

The report by parliament's health committee painted a chaotic picture of the Central Drugs Standard Control Organisation (CDSCO), which oversees the licensing, marketing and trials of drugs in India.

Why India would do well to heed US advice on drug safety

Indian drug makers will eventually have to invest in infrastructure and commit to high quality standards to ensure they get market access to America.